2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Table 4 Retired STEMI and NSTEMI Measures From the 2008 Set AMI indicates acute myocardial infarction; LDL, low-density lipoprotein; NSTEMI, non-ST-elevation myocardial infarction; PM, performance measure; QM, quality measure; and STEMI, ST-elevation myocardial infarction. # Care Setting Measure Title Rationale for Retiring the Measure PM-12 Inpatient Adult Smoking Cessation Advice/Counseling This measure is being retired because perfect scores are consistently achieved and the measure appears to have reached a ceiling effect. [...]given absence of room for further improvement, the writing committee opted to omit this measure from the inpatient performance measure set for AMI (realizing also that a separate outpatient CAD measure set will likely address smoking cessation advice/counseling). [...]the benefit of fibrinolytic therapy is most effective when provided promptly, and the ACCF/AHA guideline set a benchmark time goal from hospital arrival to drug administration, or DTN time, to be 5.0 mEq/L]) Patient currently enrolled in a clinical trial related to AMI (e.g., trials involving renin-angiotensin-aldosterone system inhibitors) Measurement Period Encounter Sources of Data Medical record or other database (e.g., administrative, clinical, registry) Attribution Measure reportable at the facility or provider level Care Setting Inpatient Rationale The EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival) stu